The 34th TROG Cancer Research Annual Scientific Meeting (ASM) was held face to face from 30 June to 3 July 2022 at the RACV Royal Pines Resort, Gold Coast, Queensland.
The 2022 ASM hosted several internationally and nationally recognised keynote speakers and TROG Cancer Research scientists and clinicians.
Over 270 delegates participated in the ASM, including leading Australian and New Zealand Radiation Oncologists, Radiation Therapists, Interventional Oncologists, Medical Physicists, and Clinical Trials Specialists.
In 2022 we re-united members of the health industry in a controlled and safe environment on the Gold Coast. The Gold Coast is a vibrant city of sun, surf and sand hosting world-class beaches and great activities to suit everyone’s interests and that of the family too. We hope you all enjoyed coming back together for our in-person event and gained a lot of valuable insight from our range of speakers and hosted workshops.
The theme of the 2022 ASM was Emerging and Evolving, which explored new ways of thinking about research methodologies, emerging clinical trial concepts, and the continued enhancement of collaborative research capabilities.
Our 2022 ASM hosted a number of keynote speakers as we took a closer look at emerging topics in radiation medicine research. Our ASM hosted more than 250 delegates from Australia and New Zealand, making for an excellent networking and engagement opportunity.
The ASM Program Committee developed a diverse and innovative program, which included collaborative workshops, scientific sessions showcasing ongoing clinical trials, discussion of new clinical trials and future research strategies.
The ASM Program Committee developed a full and extensive program, which included collaborative workshops, scientific sessions showcasing radiation oncology clinical trials, discussion of new clinical trials, future research directions, new technology and other research developments.
The Clinical Education Research Workshop and SMART Radiation Oncology Trainee Workshop were hosted concurrently on Monday 30 June 2022.
The Technical Research Workshop was run as a concurrent session to the main plenary ASM program.
For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.
Keep up to date with TROG news, subscribe to our community newsletter.
ABN: 45 132 672 292